v3.25.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
 4 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2025
Cash flows from operating activities    
Net income $ 477,000 $ 4,263,000
Adjustments to reconcile net income to net cash used in operating activities:    
Income earned on investments held in Trust Account (620,000) (7,168,000)
Credit for over-allotment liability expired (136,000)
Formation expenses paid directly by Founders 16,000
Changes in operating assets and liabilities:    
Decrease (increase) in prepaid expenses (274,000) 80,000
Increase in accounts payable 25,000 24,000
Increase in accrued liabilities 67,000 211,000
Increase in deferred legal fees 1,339,000
Increase in deferred compensation – related parties 55,000 594,000
Net cash used in operating activities (390,000) (657,000)
Cash used in investing activities    
Investment of cash into Trust Account (221,100,000)
Net cash used in investing activities (221,100,000)
Cash flows from financing activities    
Proceeds from Sponsor Note 150,000
Repay Sponsor Note (209,000)
Proceeds from sale of Units net of underwriting discounts and reimbursements 218,000,000
Proceeds from sale of Private Placement Warrants 5,500,000
Payment of offering costs (535,000)
Net cash provided by financing activities 222,906,000
Net (decrease) increase in cash 1,416,000 (657,000)
Cash – beginning of period 1,088,000
Cash – end of period 1,416,000 431,000
Supplemental disclosure of noncash activities:    
Deferred offering costs waiver by underwriter 7,700,000
Deferred offering costs and general and administrative costs paid by Sponsor in exchange for issuance of Class B ordinary shares 9,000
Deferred underwriting payable 7,700,000
Deferred legal fees 290,000
Deferred offering costs included in accounts payable 39,000
Deferred offering costs paid directly by Sponsor through promissory note $ 59,000